These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5921635)

  • 1. Antigenic behavior of Walker 256 tumor in Sprague-Dawley rats.
    Buinauskas P; Brown ER; Cole WH
    Surgery; 1966 Oct; 60(4):902-7. PubMed ID: 5921635
    [No Abstract]   [Full Text] [Related]  

  • 2. Feto-tumor serum antigens. Serologic studies with the Walker 256 tumor-rat model.
    Harshman S
    J Natl Cancer Inst; 1971 Oct; 47(4):871-80. PubMed ID: 4999592
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of immunization with antigens from heterologous and autologous liver on metastasis of Walker carcinosarcoma in parabiontic rats].
    Maĭskiĭ IN; Khundanov LL
    Biull Eksp Biol Med; 1967 Jun; 63(6):94-6. PubMed ID: 5622622
    [No Abstract]   [Full Text] [Related]  

  • 4. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
    Lehmann FE; Meyer V
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
    [No Abstract]   [Full Text] [Related]  

  • 5. Inducing tumor immunity by specific tumor antigens.
    Schwind JV
    Oncology; 1975; 32(5-6):324-6. PubMed ID: 1228544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth suppression of subcutaneously inoculated hepatic tumors after injection of syngeneic liver cells into the subcutaneous tissue of rats.
    Kamei H; Kondo T; Momoi T; Terabe K; Sugimoto K
    J Natl Cancer Inst; 1976 Feb; 56(2):415-7. PubMed ID: 176387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production and properties of an antiserum against the RP 2-L-fraction of histones from the Walker tumor of rats].
    Bauer K; Beheim P
    Z Krebsforsch; 1968; 70(3):241-5. PubMed ID: 4233639
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunity following cauterization.
    Rosen RG; Gardner B; Reiter B
    Surg Forum; 1968; 19():94-5. PubMed ID: 5718435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characterization study of the autoantigenic reaction between serum and spleen in rats].
    Dufour D; Tremblay A
    Bull Assoc Fr Etud Cancer; 1965; 52(2):179-84. PubMed ID: 5847732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relations between tumor growth and immunity].
    Keller R
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1148-51. PubMed ID: 5055034
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive activity of succinylacetone.
    Tschudy DP; Hess RA; Frykholm BC; Blaese RM
    J Lab Clin Med; 1982 Apr; 99(4):526-32. PubMed ID: 7061925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supression of species resistance in mice to rat tumor (Walker 256 carcinosarcoma) by rat thymus antiserum.
    Anigstein L; Anigstein DM; Rennels EG
    Tex Rep Biol Med; 1967; 25(2):214-22. PubMed ID: 6035439
    [No Abstract]   [Full Text] [Related]  

  • 13. Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.
    Schanoski AS; Cavalcanti TC; Campos CB; Viera-Matos AN; Rettori O; Guimarães F
    Cancer Lett; 2004 Jul; 211(1):119-27. PubMed ID: 15194224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of tumor homograft immunity during the graft-versus-host reaction.
    Medzihradský J
    Neoplasma; 1966; 13(2):223-6. PubMed ID: 5911878
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis.
    Zakharova LA; Khegai II; Sharova NP; Melnikova VI; Karpova YD; Astakhova TM; Popova NA; Ivanova LN
    Cell Immunol; 2011; 271(2):385-91. PubMed ID: 21889127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation, characterization, and antigenicity of malignolipin-like material from normal and tumor tissue.
    Petering HG; Van Giessen GJ; Buskirk HH; Crim JA; Evans JS; Musser EA
    Cancer Res; 1967 Jan; 27(1):7-14. PubMed ID: 6020367
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of antibody formation and inhibition of 256 Walker carcinosarcoma development in rats treated with low-molecular-weight thymic polypeptides (TP2).
    Milcu SM; Boeru V; Prahoveanu E; Zimel A; Ghinea E; Petrescu A
    Endocrinologie; 1979; 17(1):23-8. PubMed ID: 432520
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats.
    Mafanasyeva MA; Zakharova LA; Khegai II; Sharova NP; Popova NA; Ivanova LN; Melnikova VI
    Dokl Biochem Biophys; 2010; 430():11-3. PubMed ID: 20380153
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental antibodies to Walker ascitic tumor cell nuclei: their production and biological activity.
    Zitnan D; Cebecauer L; Ujházy V
    Experientia; 1968 Oct; 24(10):1057-8. PubMed ID: 4886131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Animal experimental studies on the problem of isosensitazation with tumor proteins. II. Exchange transplantations of tumors in different animal strains].
    Scheiffarth F; Götz H; Mundhenke U
    Med Exp Int J Exp Med; 1968; 18(2):95-102. PubMed ID: 5755034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.